1.78
price down icon2.20%   -0.04
after-market Handel nachbörslich: 1.82 0.04 +2.25%
loading
Schlusskurs vom Vortag:
$1.82
Offen:
$1.82
24-Stunden-Volumen:
167.75K
Relative Volume:
0.51
Marktkapitalisierung:
$1.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.26M
KGV:
-0.0332
EPS:
-53.609
Netto-Cashflow:
$-12.17M
1W Leistung:
+21.92%
1M Leistung:
-59.23%
6M Leistung:
-84.52%
1J Leistung:
-98.13%
1-Tages-Spanne:
Value
$1.69
$1.93
1-Wochen-Bereich:
Value
$1.42
$2.11
52-Wochen-Spanne:
Value
$1.10
$106.04

Gri Bio Inc Stock (GRI) Company Profile

Name
Firmenname
Gri Bio Inc
Name
Telefon
(619) 400-1171
Name
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
GRI's Discussions on Twitter

Vergleichen Sie GRI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GRI
Gri Bio Inc
1.78 1.06M 0 -8.26M -12.17M -53.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Gri Bio Inc Stock (GRI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-09 Eingeleitet H.C. Wainwright Buy

Gri Bio Inc Aktie (GRI) Neueste Nachrichten

pulisher
Apr 24, 2025

GRI Bio Inc (GRI) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 24, 2025
pulisher
Apr 17, 2025

FY2025 Earnings Forecast for GRI Bio Issued By HC Wainwright - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

GRI Bio appoints Withum as new accounting firm By Investing.com - Investing.com Canada

Apr 16, 2025
pulisher
Apr 16, 2025

GRI Bio Announces Abstract Selected for Poster Discussion - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Major Scientific Breakthrough: GRI Bio's Novel Pulmonary Fibrosis Treatment Shows Promise - Stock Titan

Apr 16, 2025
pulisher
Apr 16, 2025

GRI Bio appoints Withum as new accounting firm - Investing.com Australia

Apr 16, 2025
pulisher
Apr 15, 2025

GRI Bio (NASDAQ:GRI) Given Buy Rating at HC Wainwright - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

H.C. Wainwright maintains Buy on GRI Bio stock, $10 target - Investing.com Australia

Apr 15, 2025
pulisher
Apr 14, 2025

H.C. Wainwright maintains Buy on GRI Bio stock, $10 target By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 09, 2025

GRI stock touches 52-week low at $1.2 amid market fluctuations - Investing.com

Apr 09, 2025
pulisher
Apr 04, 2025

GRI Bio regains compliance with Nasdaq’s minimum bid price rule - MSN

Apr 04, 2025
pulisher
Apr 03, 2025

GRI Bio Announces Closing of $5.0 Million Public Offering - The Manila Times

Apr 03, 2025
pulisher
Apr 02, 2025

GRI Stock Down on Public Offering Despite Encouraging IPF Study Data - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Gri Bio Announces Closing Of $5.0 Million Public Offering - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Bio Raises $5M, Eyes $18.3M Total Potential for Breakthrough Autoimmune Treatment - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Stock Down On Public Offering Despite Encouraging IPF Study Data - Barchart.com

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Bio Shares Rebound In After-Hours Trading - Stocks Telegraph

Apr 02, 2025
pulisher
Apr 01, 2025

GRI Bio (GRI) Reports Positive Interim Safety Results for IPF Tr - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Street can a-GRI on phase IIb safety win in IPF with tazarotene - BioWorld MedTech

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Announces $5 Million Public Offering Amid Market Decline - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Prices up to $13 Million Equity Offering - marketscreener.com

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio announces $5 million public offering - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio announces $5 million public offering By Investing.com - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Announces Pricing of $5.0 Million Public Offering - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Secures $5M Funding Deal: Warrants Could Add $13.3M More - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?GRI Bio (NASDAQ:GRI) - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio’s IPF drug shows promise in early trial By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis ("IPF - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio reports interim 2-week safety results from Phase 2a study of GRI-0621 - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio’s IPF drug shows promise in early trial - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Gri Bio IncIDMC Recommends Continuation Of Study With No Safety Concerns - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Reports Encouraging Interim 2-Week Safety Results - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Clinical Trial Breakthrough: GRI-0621 Clears Key Safety Milestone for IPF Treatment - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

GRI Bio secures global patents for NKT cell modulators By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio secures global patents for NKT cell modulators - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio announces the granting of two global patents for Europe, Japan - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Global Patent Victory: GRI Bio's Breakthrough NKT Cell Treatment for Autoimmune Disease Gets Dual Approval - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Vallon Pharmaceuticals stock plunges to 52-week low of $4.95 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Vallon Pharmaceuticals stock plunges to 52-week low of $4.95 - Investing.com India

Mar 28, 2025
pulisher
Mar 20, 2025

GRI Bio (GRI) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

GRI Bio Participates in a Virtual Investor CEO Connect Segment - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

GRI Bio's Breakthrough IPF Drug Shows Promise, Key Data Coming Next Quarter - StockTitan

Mar 18, 2025

Finanzdaten der Gri Bio Inc-Aktie (GRI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Kapitalisierung:     |  Volumen (24h):